APA (7th ed.) Citation

Arévalo-Herrera, M., Miura, K., Solano, E., Sebastián Ramírez, J., Long, C. A., Corradin, G., & Herrera, S. (2022). Immunogenicity of full-length P. vivax rPvs48/45 protein formulations in BALB/c mice. Vaccine, 40(1), 133-140. https://doi.org/10.1016/j.vaccine.2021.11.036

Chicago Style (17th ed.) Citation

Arévalo-Herrera, Myriam, Kazutoyo Miura, Eduardo Solano, Juan Sebastián Ramírez, Carole A. Long, Giampietro Corradin, and Sócrates Herrera. "Immunogenicity of Full-length P. Vivax RPvs48/45 Protein Formulations in BALB/c Mice." Vaccine 40, no. 1 (2022): 133-140. https://doi.org/10.1016/j.vaccine.2021.11.036.

MLA (9th ed.) Citation

Arévalo-Herrera, Myriam, et al. "Immunogenicity of Full-length P. Vivax RPvs48/45 Protein Formulations in BALB/c Mice." Vaccine, vol. 40, no. 1, 2022, pp. 133-140, https://doi.org/10.1016/j.vaccine.2021.11.036.